Quarterly report pursuant to Section 13 or 15(d)

Accounts Receivable (Details Narrative)

v3.22.1
Accounts Receivable (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Sep. 14, 2021
Mar. 31, 2022
Sep. 30, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]            
Bad debts   $ 1,400,000   $ 3,000,000.0    
Allowance for doubtful accounts   1,038,274     $ 1,456,791  
Accounts receivable sales           $ 3,300,000
Proceeds from accounts Receivable securitization           2,200,000
Loan origination fees           100,000
Gain (loss) on sale of accounts receivable           1,200,000
Accounts receivable           $ 1,700,000
Three Funding Parties [Member] | Sales Agreements [Member]            
Defined Benefit Plan Disclosure [Line Items]            
Accounts receivable   $ 500,000     700,000  
Amount need to be paid $ 900,000          
Monthly payments         $ 52,941  
Gain from legal settlements     $ 600,000